New York is the latest state to introduce its own health privacy law, the NY Health Information Privacy Act (NYHIPA), signaling a growing trend of state-level regulations extending beyond HIPAA. If enacted, NYHIPA will impose strict requirements on how businesses—both inside and outside the healthcare industry—collect, process, and share consumer health data, making compliance a priority for many organizations.
Read MoreDiscover the top trends and opportunities for digital health innovators in 2025, from AI adoption and value-based care to regulatory shifts and cybersecurity challenges. These insights from Nixon Law Group will help you navigate the year ahead.
Read MoreExplore how venture debt can offer healthcare innovation companies non-dilutive capital to fuel growth, bridge equity rounds, and scale operations, while navigating key legal and financial considerations to maximize value.
Read MoreExplore how strategic mergers and acquisitions (M&A) can reduce or even eliminate point solution fatigue by creating more comprehensive and integrated platforms that will improve patient care and reduce administrative burden.
Read MoreThe Federal Trade Commission (FTC) finalized changes to the Health Breach Notification Rule (HBNR), clarifying its applicability to health apps and similar technologies, including those that are not subject to HIPAA. In 2023, FTC began enforcing the HBNR in earnest, with an expanded interpretation of their authority under the HBNR. In the 2024 Final Rule (the 2024 Final Rule), the agency conforms the HBNR to this expanded interpretation, clarifying its breadth for industry and the public.
Read MoreLast Friday, Colorado’s governor signed into law the Colorado AI Act (“CAIA”). For digital health companies building with artificial intelligence, CAIA sets the first comprehensive national benchmark for minimum rights and protections for users of healthcare AI, effective February 1, 2026.
Read MoreOn January 13, 2022, in response to numerous legal challenges premised on the lack or abuse of executive authority.
Read MoreFor the first time, the Drug Enforcement Agency (“DEA”) is becoming directly involved in the telepharmacy space, an industry that the DEA has not previously regulated aside from the loose application of its existing regulations governing online pharmacies. Find out what this means for your business and how you can submit comments to the DEA directly in this post.
Read More
![[March 2024 Update] Key Pitfalls to Avoid when using Tracking Technologies for DTC Digital Health and Telemedicine Performance Marketing](https://images.squarespace-cdn.com/content/v1/563c7acce4b028323896cb89/1707926471045-L3WYKDLO9YNILMXYVUU9/Tracking+Technology+square+blog+post+image_NGL.png){kind=tracking}
![[Video] What Digital Health Innovators Need to Know about the 2023 MPFS and Recently Passed Consolidation Appropriations Act](https://images.squarespace-cdn.com/content/v1/563c7acce4b028323896cb89/1674156595370-T2KPEDGK5MX9RSXIRTTU/Replay+for+blog_+2023+MPFS+Webinar+%28square%29.png)
